Brandi Roberts
Vice President, Finance, Savara Inc.
Companies
- Definium TherapeuticsChief financial officer Jun 2, 2025 to now1
- Longboard Pharmaceuticals, Inc.Chief financial officer Mar 11, 2021 to Dec 2, 20242
- TFF Pharmaceuticals, Inc.Board member Apr 4, 2022 to Jul 8, 20243
- Lineage Cell TherapeuticsChief financial officer Jan 9, 2019 to Mar 19, 20204
- Savara IncChief financial officer Jan 3, 2013 to Jan 23, 20175
- Savara IncVice President, Finance Mar 23, 2011 to Dec 9, 20116
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Definium Therapeutics DFTX394,528 shares7$13.5M at $34.31Sep 25, 2026
- TFF Pharmaceuticals, Inc.23,165 shares8Jul 3, 2024
- Longboard Pharmaceuticals, Inc.15,090 shares9Feb 8, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 25, 2026Sold 3,377 shares at $36.57 of Definium Therapeutics7
- Sep 14, 2026Granted 125,000 shares of Definium Therapeutics10
- Aug 12, 2026Granted 62,500 shares of Definium Therapeutics11
- Jun 25, 2026Sold 3,013 shares at $45.03 of Definium Therapeutics12
- Jun 22, 2026Granted 62,500 shares of Definium Therapeutics13
- Feb 3, 2026Granted 150,000 shares of Definium Therapeutics14
- Jul 3, 2024Granted 3,165 shares of TFF Pharmaceuticals, Inc.8
- Feb 8, 2024Granted 15,090 shares of Longboard Pharmaceuticals, Inc.9
- Aug 15, 2023Bought 20,000 shares at $0.25 of TFF Pharmaceuticals, Inc.15
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARSavara Inc, Chief financial officer
- 6SEC EDGARSavara Inc, Vice President, Finance
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Sep 14, 2026
- 11SEC EDGARForm 4 filed Aug 12, 2026
- 12SEC EDGARForm 4 filed Jun 26, 2026
- 13SEC EDGARForm 4 filed Jun 22, 2026
- 14SEC EDGARForm 4 filed Feb 5, 2026
- 15SEC EDGARForm 4 filed Aug 15, 2023